Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S. 
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure 
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 
SAN FRANCISCO, March 16, 2017 -- Hagens Berman Sobol Shapiro LLP reminds investors in AmTrust Financial Services Inc. (NASDAQ:AFSI) of the May 1, 2017 Lead Plaintiff deadline in the pending securities class action related to admitted material weaknesses in internal controls.
If you purchased or otherwise acquired securities of AFSI between May 10, 2016 and February 24, 2017 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/AFSI
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
On February 27, 2017 AmTrust disclosed it would not timely file its 2016 annual financial statements. The Company explained it “identified material weaknesses in its internal control over financial reporting that existed as of December 31, 2016, specifically related to ineffective assessment of the risks associated with the financial reporting, and an insufficient complement of corporate accounting and corporate financial reporting resources within the organization.”
This news drove the price of AmTrust shares down over 15% during intraday trading on February 27, 2017.
“We’re concerned about the admitted material weaknesses in internal controls over financial reporting and whether there will be a restatement of financial statements,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding AmTrust should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000
